151 related articles for article (PubMed ID: 31853197)
21. Erratum: ITPKA1 Promotes Growth, Migration and Invasion of Renal Cell Carcinoma via Activation of mTOR Signaling Pathway [Corrigendum].
Onco Targets Ther; 2021; 14():5051-5053. PubMed ID: 34703246
[TBL] [Abstract][Full Text] [Related]
22. Stanniocalcin 2 promotes invasion and is associated with metastatic stages in neuroblastoma.
Volland S; Kugler W; Schweigerer L; Wilting J; Becker J
Int J Cancer; 2009 Nov; 125(9):2049-57. PubMed ID: 19582875
[TBL] [Abstract][Full Text] [Related]
23. Stanniocalicin 2 suppresses breast cancer cell migration and invasion via the PKC/claudin-1-mediated signaling.
Hou J; Wang Z; Xu H; Yang L; Yu X; Yang Z; Deng Y; Meng J; Feng Y; Guo X; Yang G
PLoS One; 2015; 10(4):e0122179. PubMed ID: 25830567
[TBL] [Abstract][Full Text] [Related]
24. Erratum: IL-33 Promotes the Growth of Non-Small Cell Lung Cancer Cells Through Regulating miR-128-3p/CDIP1 Signalling Pathway [Corrigendum].
Cancer Manag Res; 2021; 13():2907. PubMed ID: 33833573
[TBL] [Abstract][Full Text] [Related]
25. Erratum: Upregulation of hsa_circRNA_102958 Indicates Poor Prognosis and Promotes Ovarian Cancer Progression Through miR-1205/SH2D3A Axis [Corrigendum].
Cancer Manag Res; 2020; 12():6863. PubMed ID: 32848459
[TBL] [Abstract][Full Text] [Related]
26. STC2 promotes head and neck squamous cell carcinoma metastasis through modulating the PI3K/AKT/Snail signaling.
Yang S; Ji Q; Chang B; Wang Y; Zhu Y; Li D; Huang C; Wang Y; Sun G; Zhang L; Guan Q; Xiang J; Wei W; Lu Z; Liao T; Meng J; Wang Z; Ma B; Zhou L; Wang Y; Yang G
Oncotarget; 2017 Jan; 8(4):5976-5991. PubMed ID: 27863406
[TBL] [Abstract][Full Text] [Related]
27. Erratum: Drug-Related Hypertension Associated with the Efficacy of Apatinib on Hepatocellular Carcinoma [Corrigendum].
Cancer Manag Res; 2020; 12():4169-4170. PubMed ID: 32581588
[TBL] [Abstract][Full Text] [Related]
28. Erratum: Assessment of Potential Prognostic Value of Peroxiredoxin 1 in Oral Squamous Cell Carcinoma [Corrigendum].
Cancer Manag Res; 2021; 13():7055-7056. PubMed ID: 34531683
[TBL] [Abstract][Full Text] [Related]
29. Erratum: Assessment of Potential Prognostic Value of Peroxiredoxin 1 in Oral Squamous Cell Carcinoma [Corrigendum].
Cancer Manag Res; 2021; 13():6797-6798. PubMed ID: 34512019
[TBL] [Abstract][Full Text] [Related]
30. Effect of STC2 gene silencing on colorectal cancer cells.
Li Q; Zhou X; Fang Z; Pan Z
Mol Med Rep; 2019 Aug; 20(2):977-984. PubMed ID: 31173256
[TBL] [Abstract][Full Text] [Related]
31. Erratum: Oridonin Sensitizes Hepatocellular Carcinoma to the Anticancer Effect of Sorafenib by Targeting the Akt Pathway [Corrigendum].
Cancer Manag Res; 2021; 13():2515. PubMed ID: 33776476
[TBL] [Abstract][Full Text] [Related]
32. Stanniocalcin-2 May Be a Potentially Valuable Prognostic Marker in Endometrial Cancer: a Preliminary Study.
Aydin HA; Toptas T; Bozkurt S; Aydin A; Erdogan G; Pestereli E; Simsek T
Pathol Oncol Res; 2019 Apr; 25(2):751-757. PubMed ID: 30661222
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance of stanniocalcin 2 expression as a predictor of tumor progression in gastric cancer.
Arigami T; Uenosono Y; Ishigami S; Yanagita S; Hagihara T; Haraguchi N; Matsushita D; Hirahara T; Okumura H; Uchikado Y; Nakajo A; Hokita S; Natsugoe S
Oncol Rep; 2013 Dec; 30(6):2838-44. PubMed ID: 24100594
[TBL] [Abstract][Full Text] [Related]
34. Erratum: [Corrigendum] Upregulation of LINC00659 expression predicts a poor prognosis and promotes migration and invasion of gastric cancer cells.
Gong P; Xu Y; Liu M; Shen X; Mao Y; Li Y; Zhang K; Yu S; Fan H
Oncol Lett; 2023 May; 25(5):199. PubMed ID: 37113394
[TBL] [Abstract][Full Text] [Related]
35. Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma.
Meyer HA; Tölle A; Jung M; Fritzsche FR; Haendler B; Kristiansen I; Gaspert A; Johannsen M; Jung K; Kristiansen G
Eur Urol; 2009 Mar; 55(3):669-78. PubMed ID: 18450365
[TBL] [Abstract][Full Text] [Related]
36. Erratum: Long Noncoding RNA GAS5 Acts As A Tumor Suppressor In Laryngeal Squamous Cell Carcinoma Via miR-21 [Corrigendum].
Cancer Manag Res; 2019; 11():9047. PubMed ID: 31695496
[TBL] [Abstract][Full Text] [Related]
37. Erratum: Disulfiram Inhibits Epithelial-Mesenchymal Transition Through TGF
Cancer Manag Res; 2021; 13():8647-8650. PubMed ID: 34858055
[TBL] [Abstract][Full Text] [Related]
38. Erratum: Secondary Nasopharyngeal Mixed Adenoneuroendocrine Carcinoma After Radical Radiotherapy for Nasopharyngeal Carcinoma: A Rare Case and Literature Review [Corrigendum].
Onco Targets Ther; 2022; 15():21-22. PubMed ID: 35035221
[TBL] [Abstract][Full Text] [Related]
39. Erratum: Prognostic Factors and Local Treatment Modalities of Small-Cell Carcinoma of the Cervix: An Analysis According to the International Federation of Gynecology and Obstetrics Stage [Corrigendum].
Cancer Manag Res; 2020; 12():6239. PubMed ID: 32884338
[TBL] [Abstract][Full Text] [Related]
40. Erratum:
Onco Targets Ther; 2020; 13():10761. PubMed ID: 33116649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
